Back to Search
Start Over
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1994 Jun; Vol. 38 (6), pp. 1402-3. - Publication Year :
- 1994
-
Abstract
- The in vitro susceptibilities of 12 strains of Chlamydia pneumonia to a new quinolone, OPC-17116; ofloxacin; and sparfloxacin were determined. OPC-17116 was slightly less active than sparfloxacin but more active than ofloxacin, with a MIC for 90% of strains tested and a minimal chlamydiacidal concentration for 90% of strains tested of 0.5 micrograms/ml.
Details
- Language :
- English
- ISSN :
- 0066-4804
- Volume :
- 38
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 8092845
- Full Text :
- https://doi.org/10.1128/AAC.38.6.1402